Actively Recruiting

Age: 18Years - 85Years
All Genders
NCT03014609

Cardiovascular Risk and Chronic Obstructive Pulmonary Disease

Led by University Hospital, Grenoble · Updated on 2023-05-23

150

Participants Needed

1

Research Sites

672 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The principal objective of the study is to measure parameters of inflammation, oxidative stress, and vascular, respiratory, and peripheral muscle function parameters, and identify parameters indicative of evolving cardiovascular risk (CVR) in COPD patients, using multivariate analysis.

CONDITIONS

Official Title

Cardiovascular Risk and Chronic Obstructive Pulmonary Disease

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men or women aged 18 to 85 years
  • FEV1/FVC less than 70% or proven chronic obstructive pulmonary disease (BPCO)
  • Patients who have given their free and informed consent in writing
  • For decompensated COPD patients at hospital admission with acute respiratory failure: respiratory rate greater than 25 cycles per minute, PaCO2 greater than 45 mmHg, and blood pH less than 7.35
  • For inclusion after acute respiratory failure: blood pH greater than 7.33 for two days in a row or 3 to 7 days after hospital admission
  • Body temperature less than 38.5°C at inclusion
Not Eligible

You will not qualify if you...

  • Obvious evolving infection or C-reactive protein (CRP) greater than 100 mg/L
  • Cardiac decompensation as the main cause of decompensation or chronic heart failure with left ventricular ejection fraction less than 45%
  • Evolving neoplasia
  • Use of antioxidants such as N-acetyl-cysteine, selenium, vitamin C, or vitamin E
  • Pregnant or nursing women
  • Patients under tutorship or curatorship
  • Patients participating in another drug clinical research study
  • Patients not affiliated with the French social security system or equivalent
  • Patients deprived of liberty or hospitalized without consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Grenoble Hospital

Grenoble, La Tronche, France, 38700

Actively Recruiting

Loading map...

Research Team

J

Jean-Louis PEPIN, ProfessorPHD

CONTACT

S

Sandrine BOUZON, CRA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here